16:19 EDT Maravai Lifesciences backs FY24 revenue view $265M-$285M, consensus $275.44M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVI:
- Maravai LifeSciences Reports Second Quarter 2024 Financial Results
- Maravai Lifesciences Announces New Board Member Appointment
- Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
- Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
- Applied DNA, Alphazyme conclude Linea RNAP manufacturing scale-up project